News

This month, we’re hearing from women leaders in biotech on the challenges they face and their vision for the future. Jill Milne, founder and CEO of Astria Therapeutics: “The challenges I face ...
Sujal Patel, CEO of Nautilus Biotechnology Nautilus CEO Sujal Patel. (Nautilus Photo) Patel previously helped launch and lead Isilon Systems, which sold to EMC for $2.25 billion in 2010.
Biotech-startup CEOs are taking more nuanced approaches to going public amid a downturn. Insider talked to the leaders of five privately held biotechs for their views on IPOs in 2023.
Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.